Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial
2016 ◽
Vol 17
(8)
◽
pp. 1127-1136
◽
Keyword(s):
Phase 3
◽
Keyword(s):
1998 ◽
Vol 21
(11)
◽
pp. 1101-1107
◽
Keyword(s):
2015 ◽
Vol 15
◽
pp. e73-e74
◽
2008 ◽
Vol 141
(4)
◽
pp. 512-516
◽